(ACAD) Acadia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Acadia Pharmaceuticals | (ACAD) share price targets
Complete technical analysis of Acadia Pharmaceuticals (ACAD) by charts plus indicators, forecast predictions and share price targets for Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-11-04 View latest technical analysis
10 day averaged volume of Acadia Pharmaceuticals is 1532233
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Tue Nov 2025 | 21.85 | 21.98 | 22.20 | 21.72 | 0.904 times |
| 31 Fri Oct 2025 | 22.70 | 22.55 | 22.91 | 22.25 | 0.924 times |
| 31 Fri Oct 2025 | 22.70 | 22.55 | 22.91 | 22.25 | 0.924 times |
| 30 Thu Oct 2025 | 22.74 | 22.24 | 22.88 | 22.15 | 0.777 times |
| 29 Wed Oct 2025 | 22.53 | 22.55 | 22.92 | 22.05 | 1.358 times |
| 28 Tue Oct 2025 | 22.62 | 22.99 | 23.05 | 22.55 | 0.868 times |
| 27 Mon Oct 2025 | 22.99 | 22.25 | 23.01 | 21.96 | 1.443 times |
| 24 Fri Oct 2025 | 22.03 | 21.81 | 22.19 | 21.48 | 0.704 times |
| 23 Thu Oct 2025 | 21.73 | 21.27 | 21.75 | 21.07 | 1.058 times |
| 22 Wed Oct 2025 | 21.39 | 21.27 | 21.41 | 20.88 | 0.954 times |
My analysis of stock is bullish for shortterm, and stock might move up till 22.5 or till 23.6. Use a stoploss of 21.55 and if this stock hits its stoploss, then it can fall down till 20.62
Share price targets for Acadia Pharmaceuticals (ACAD)
| Target Type | Value |
| Downside Target | 19.69 |
| Downside Target | 20.75 |
| Downside Target | 21.72 |
| Upside Target | 22.25 |
| Upside Target | 22.91 |
| Upside Target | 23.05 |
| Upside Target | 23.25 |
| Upside Target | 24.06 |
| Upside Target | 26.50 |
| Upside Target | 26.65 |
Intraday share price targets for Acadia Pharmaceuticals (ACAD)
| Target Type | Value |
| Downside Intraday Target | 21.65 |
| Downside Intraday Target | 21.44 |
| Upside Intraday Target | 22.13 |
| Upside Intraday Target | 22.4 |
| Upside Intraday Target | 21.92 |
Weekly technical analysis of Acadia Pharmaceuticals (ACAD)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Tue Nov 2025 | 21.85 | 21.98 | 22.20 | 21.72 | 0.979 times |
| 31 Fri Oct 2025 | 22.70 | 22.55 | 22.91 | 22.25 | 0.172 times |
| 31 Fri Oct 2025 | 22.70 | 22.25 | 23.05 | 21.96 | 1.122 times |
| 24 Fri Oct 2025 | 22.03 | 21.05 | 22.19 | 20.75 | 0.605 times |
| 17 Fri Oct 2025 | 20.89 | 20.59 | 22.10 | 19.69 | 1.094 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Acadia Pharmaceuticals (ACAD)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Tue Nov 2025 | 21.85 | 21.98 | 22.20 | 21.72 | 0.031 times |
| 31 Fri Oct 2025 | 22.70 | 21.33 | 23.05 | 19.69 | 0.912 times |
| 30 Tue Sep 2025 | 21.34 | 25.99 | 26.50 | 20.02 | 1.166 times |
| 29 Fri Aug 2025 | 25.99 | 23.70 | 26.65 | 23.25 | 1.123 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Acadia Pharmaceuticals (ACAD)
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Acadia Pharmaceuticals in short term but the buy signal is initial and weak.
Acadia Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.36 and Acadia Pharmaceuticals (ACAD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Acadia Pharmaceuticals in short term but the buy signal is initial and weak.
Acadia Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.36 and Acadia Pharmaceuticals (ACAD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.